Quality Adjustment for Health Care Spending on Chronic Disease: Evidence from Diabetes Treatment, 1999–2009

Author(s)
Eggleston, Karen N; Shah, Nilay D; Smith, Steven A; Berndt, Ernst R.; Newhouse, Joseph P.
Thumbnail
DownloadBerndt_Quality adjustment.pdf (506.7Kb)
PUBLISHER_POLICY
Terms of use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Metadata
Show full item record
Abstract
Although US health care expenditures reached 17.6 percent of GDP in 2009, quality measurement in this important service sector remains limited. Studying quality changes associated with 11 years of health care for patients with diabetes, we find that the value of reduced mortality and avoided treatment spending, net of the increase in annual spending, was $9,094 for the average patient. These results suggest that the unit cost of diabetes treatment, adjusting for the value of health outcomes, has been roughly constant. Since input prices have not been declining, our results are consistent with productivity improvement in health care.
Date issued
2011-05
URI
http://hdl.handle.net/1721.1/87608
Department
Sloan School of Management
Journal
American Economic Review
Publisher
American Economic Association
Citation
Eggleston, Karen N, Nilay D Shah, Steven A Smith, Ernst R Berndt, and Joseph P Newhouse. “Quality Adjustment for Health Care Spending on Chronic Disease: Evidence from Diabetes Treatment, 1999–2009.” American Economic Review 101, no. 3 (May 2011): 206–211.
Version: Final published version
ISSN
0002-8282
Collections